PPC
TMO icon

Park Place Capital’s Thermo Fisher Scientific TMO Stock Holding History

Park Place Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
2,689
+55
+2% +$26.4K 0.21% 69
2026
Q1 		$1.29M Sell
2,634
-62
-2% -$33.6K 0.26% 56
2025
Q4 		$1.56M Sell
2,696
-532
-16% -$301K 0.33% 52
2025
Q3 		$1.57M Buy
3,228
+93
+3% +$43.3K 0.33% 54
2025
Q2 		$1.32M Buy
3,135
+1,074
+52% +$449K 0.3% 60
2025
Q1 		$1.03M Sell
2,061
-615
-23% -$333K 0.28% 77
2024
Q4 		$1.39M Sell
2,676
-11
-0.4% -$6.05K 0.39% 59
2024
Q3 		$1.66M Sell
2,687
-89
-3% -$52.7K 0.48% 46
2024
Q2 		$1.54M Buy
2,776
+246
+10% +$141K 0.49% 47
2024
Q1 		$1.47M Buy
2,530
+311
+14% +$175K 0.53% 47
2023
Q4 		$1.18M Buy
2,219
+359
+19% +$174K 0.47% 58
2023
Q3 		$941K Buy
1,860
+260
+16% +$139K 0.28% 81
2023
Q2 		$835K Buy
1,600
+670
+72% +$362K 0.24% 104
2023
Q1 		$536K Sell
930
-152
-14% -$85.7K 0.15% 138
2022
Q4 		$596K Buy
+1,082
New +$573K 0.17% 135

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Park Place Capital's TMO Position: Q2 2026 in Review

Park Place Capital increased its Thermo Fisher Scientific (TMO) stake by 2.1% in Q2 2026, buying an estimated $26.4K and bringing the position to 2,689 shares worth $1.35M. The position accounts for 0.21% of the portfolio, ranked #69.

Park Place Capital first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.66M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Park Place Capital held 2,689 shares of Thermo Fisher Scientific worth $1.35M as of Q2 2026.
  • Park Place Capital bought 55 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.4K.
  • Thermo Fisher Scientific made up 0.21% of Park Place Capital's portfolio in Q2 2026, its #69 holding.
  • Park Place Capital first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Thermo Fisher Scientific position peaked at $1.66M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.